Anders Olsson
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 0.02%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
Papers in
- Surgery 146
- Lipoproteins and Cardiovascular Health 126
- Peripheral Artery Disease Management 12
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 39
- Co-authors
- John Kjekshus (12 shared papers)Ole Færgeman (24 shared papers)Kalevi Pyörälà (8 shared papers)Terje R. Pedersen (39 shared papers)John J.V. McMurray (6 shared papers)Lars Wilhelmsen (5 shared papers)Christian Spaulding (1 shared paper)R. Scott Wright (1 shared paper)
- Journals
- Atherosclerosis (40 papers)The American Journal of Cardiology (20 papers)Circulation (14 papers)Journal of Internal Medicine (13 papers)Scandinavian Journal of Clinical and Laboratory Investigation (7 papers)
- Partner nations
- SwedenUnited StatesNorway
In The Last Decade
Anders Olsson
276 papers receiving 22.5k citations
Anders Olsson's Hit Papers
Peers
Comparison fields: 5 of 177
- Endocrinology, Diabetes and Metabolism 5.6k
- Surgery 12.2k
- Cardiology and Cardiovascular Medicine 4.1k
- Transplantation 455
- Cancer Research 2.3k
Countries citing papers authored by Anders Olsson
This map shows the geographic impact of Anders Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Olsson more than expected).
Fields of papers citing papers by Anders Olsson
This network shows the impact of papers produced by Anders Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Olsson. The network helps show where Anders Olsson may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Olsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 301 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Hit paper breakdown → | 1994 | 6912 |
| 2 | Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome Hit paper breakdown → | 2012 | 1487 |
| 3 | Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Hit paper breakdown → | 1997 | 1202 |
| 4 | Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Hit paper breakdown → | 2003 | 661 |
| 5 | PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2014 | 570 |
| 6 | Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S) Hit paper breakdown → | 1998 | 478 |
| 7 | Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials Hit paper breakdown → | 2018 | 386 |
| 8 | Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment Hit paper breakdown → | 2008 | 380 |
| 9 | Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients Hit paper breakdown → | 2012 | 370 |
| 10 | 1997 | 360 | |
| 11 | 1998 | 331 | |
| 12 | 2001 | 323 | |
| 13 | 1997 | 310 | |
| 14 | 2003 | 298 | |
| 15 | 2008 | 297 | |
| 16 | 1997 | 283 | |
| 17 | 2009 | 271 | |
| 18 | 2010 | 236 | |
| 19 | 2005 | 229 | |
| 20 | 2000 | 218 |
About Anders Olsson
Anders Olsson is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Molecular Biology and Cancer Research, having authored 301 papers that have together received 23.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (126 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (39 papers), Cancer, Lipids, and Metabolism (21 papers), Antioxidant Activity and Oxidative Stress (14 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers), Peripheral Artery Disease Management (12 papers), Cardiac Imaging and Diagnostics (10 papers) and Adipokines, Inflammation, and Metabolic Diseases (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.6k citations), Surgery (12.2k citations), Cardiology and Cardiovascular Medicine (4.1k citations), Transplantation (455 citations) and Cancer Research (2.3k citations). Anders Olsson has collaborated with scholars based in Sweden, United States and Norway. Frequent co-authors include John Kjekshus, Ole Færgeman, Kalevi Pyörälà, Terje R. Pedersen, John J.V. McMurray, Lars Wilhelmsen, Christian Spaulding, R. Scott Wright, Michael Gnant and T. A. Miettinen. Their work appears in journals such as Atherosclerosis, The American Journal of Cardiology, Circulation, Journal of Internal Medicine and Scandinavian Journal of Clinical and Laboratory Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.